312 related articles for article (PubMed ID: 10393963)
1. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.
Moran JL; Siegel D; Ross D
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8150-5. PubMed ID: 10393963
[TBL] [Abstract][Full Text] [Related]
2. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
3. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity.
Ross D
Chem Biol Interact; 2005 May; 153-154():137-46. PubMed ID: 15935810
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1.
Bauer AK; Faiola B; Abernethy DJ; Marchan R; Pluta LJ; Wong VA; Roberts K; Jaiswal AK; Gonzalez FJ; Butterworth BE; Borghoff S; Parkinson H; Everitt J; Recio L
Cancer Res; 2003 Mar; 63(5):929-35. PubMed ID: 12615705
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity.
Ross D; Siegel D; Schattenberg DG; Sun XM; Moran JL
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1177-82. PubMed ID: 9118890
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
Siegel D; McGuinness SM; Winski SL; Ross D
Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
9. [Study on genetic polymorphism of NQO1 and susceptibility to benzene poisoning].
Chen Y; Ji Z; Xu J; Wu C; Li G
Wei Sheng Yan Jiu; 2004 Nov; 33(6):657-9. PubMed ID: 15727169
[TBL] [Abstract][Full Text] [Related]
10. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of tert-butylhydroquinone on bone marrow cells in rats from cytotoxicity induced by benzene in vitro].
Zhao ZW; Bi YY; Pan BQ; Zhang L; Chen XH; Ouyang JP; Ma Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Mar; 24(3):143-6. PubMed ID: 16600132
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the toxicity and macromolecular binding of benzene metabolites by NAD(P)H:Quinone oxidoreductase in transfected HL-60 cells.
Wiemels J; Wiencke JK; Varykoni A; Smith MT
Chem Res Toxicol; 1999 Jun; 12(6):467-75. PubMed ID: 10368308
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells.
Siegel D; Ryder J; Ross D
Toxicol Lett; 2001 Dec; 125(1-3):93-8. PubMed ID: 11701227
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion.
Zhou H; Dehn D; Kepa JK; Siegel D; Scott DE; Tan W; Ross D
J Pharmacol Exp Ther; 2010 Jul; 334(1):260-8. PubMed ID: 20378716
[TBL] [Abstract][Full Text] [Related]
15. Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: implications for benzene-induced hematotoxicity.
Zhu H; Li Y; Trush MA
J Toxicol Environ Health; 1995 Oct; 46(2):183-201. PubMed ID: 7563217
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG
Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782
[TBL] [Abstract][Full Text] [Related]
17. Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function.
Ross D; Zhou H; Siegel D
Chem Biol Interact; 2011 Jun; 192(1-2):145-9. PubMed ID: 20970411
[TBL] [Abstract][Full Text] [Related]
18. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
20. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity.
Iskander K; Jaiswal AK
Chem Biol Interact; 2005 May; 153-154():147-57. PubMed ID: 15935811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
